IPP Bureau
Medikabazaar conducts successful trial of medical supplies through drone delivery
By IPP Bureau - May 11, 2022
The company intends to begin using drones to make deliveries of critical and emergency medical supplies, vaccines, and lifesaving drugs after getting the prerequisite regulatory approvals
FirstCure Health raises US $350 K in the Pre-Seed funding round
By IPP Bureau - May 11, 2022
The funding will enable the company to expand into the segment of HealthCare Service offerings, both in terms of geography and operations
Alembic Pharmaceuticals receives USFDA approval for Arformoterol Tartrate
By IPP Bureau - May 11, 2022
This ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies
Dr. Reddy's to commercialise Tegoprazan in India and six emerging markets
By IPP Bureau - May 11, 2022
HK inno.N Corporation will be responsible for the manufacture and supply of Tegoprazan, while Dr. Reddy's will handle local clinical development, registration, marketing and sales
Hetero unveils new logo and corporate brand identity
By IPP Bureau - May 11, 2022
The new logo is a refreshing change from the version that has served Hetero well for three decades. And yet its reflection can be seen in the new version
DSM, UNICEF and Sight and Life extend global partnership to address malnutrition
By IPP Bureau - May 11, 2022
The partners also aim to expand their work to Latin America for the first time
New nirsevimab data analyses reinforce efficacy against RSV
By IPP Bureau - May 11, 2022
Nirsevimab is the first investigational immunization designed to protect all infants across the RSV season with a single dose
Bayer posts higher sales, profit in first quarter
By IPP Bureau - May 11, 2022
Company's net income rose by 57.5 percent to 3.291 billion euros in Q1
Aarti Drugs Q4FY 22 consolidated revenue grew by 39 per cent YoY
By IPP Bureau - May 10, 2022
The capex for FY22 stood at Rs 145 crore and is expected to be in the range of Rs 250-350 crore for the entire FY23 which would be funded through a mix of internal accruals and debt
U.S. Centers for Disease Control and Prevention selects Biobot Analytics to expand national wastewater monitoring
By IPP Bureau - May 10, 2022
NWSS works with public health departments across the country to track SARS-CoV-2 levels in wastewater so communities can act quickly to prevent the spread of Covid-19.
Myovant Sciences and Accord Healthcare partner to commercialise Orgovyx in Europe
By IPP Bureau - May 10, 2022
Myovant to receive an upfront payment of US $50 million, is eligible to receive commercial launch, sales-based and other milestones totaling up to US $90.5 million
Cipla launches ‘RT Direct’ Multiplex real-time PCR kit for Covid-19
By IPP Bureau - May 10, 2022
RNA extraction free kit to deliver results in just 45 minutes
Roche extends commitment to the World Federation of Hemophilia Humanitarian Aid Program
By IPP Bureau - May 10, 2022
The renewed commitment will provide continued preventative (prophylactic) treatment to as many as 1,000 people with haemophilia A in locations where there is little to no access to haemophilia treatment
Indian Pharma Market slips for third month in a row: Anand Rathi
By IPP Bureau - May 10, 2022
According to the brokerage, as the pandemic has receded, the past exceptional growth in acute therapies may not be repeated (stellar double-digit growth for anti-infectives coming down)
Sun gets 10 observations from USFDA for Halol facility
By IPP Bureau - May 10, 2022
The company is preparing the response to the observations, which will be submitted to the USFDA within 15 business days
